Raya Leibowitz-Amit

5PUBLICATIONS
2CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 12, 2025
Mir-16 Decreases the Expression of VTI1B and SMPD1, Genes Involved in Membrane-Protein Trafficking in Melanoma.

Adi Layani, Tal Meningher, Yechezkel Sidi

|Jun 19, 2025
Prolonged response to PIK3CA inhibition in an advanced hormone-positive breast cancer patient with 3 mutations in the alpha subunit of PI-3 kinase.

Rotem Merose, Raya Leibowitz

|Apr 26, 2021
Associations between T cell infiltration, T cell receptor clonality, histology and recurrence in renal cell carcinoma.

Moran Gadot, Mordechay Gal, Paula Dobosz

|May 21, 2020
A Retrospective Analysis of the Safety and Activity of Lutetium-177-Prostate-Specific Membrane Antigen Radionuclide Treatment in Older Patients with Metastatic Castration-Resistant Prostate Cancer.

Raya Leibowitz, Tima Davidson, Moran Gadot

|Sep 11, 2019
TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.

Jason Roszik, Ettai Markovits, Paula Dobosz

Pageof 1

Frequent Collaborators

1 joint publications

Rotem Merose

1 joint publications

Dror Avni